Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas S Heaton

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Science Signaling|July 14, 2021
ETV7 limits antiviral gene expression and control of influenza virusesHeather M Froggatt, Alfred T Harding, Ryan R Chaparian, et al.
Mbio|June 8, 2017
Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in EggsAlfred T Harding, Brook E Heaton, Rebekah E Dumm, et al.
Plos Pathogens|November 16, 2019
Influenza viruses that require 10 genomic segments as antiviral therapeuticsAlfred T Harding, Griffin D Haas, Benjamin S Chambers, et al.
Mbio|January 2, 2025
Influenza B virus infection alters the regenerative potential of murine alveolar type 2 pneumocytesSatoko Nakano, Cait E Hamele, Aleksandra Tata, et al.
Journal of Vascular Research|March 21, 2008
Antisense to transforming growth factor-beta(1) facilitates the apoptosis of macrophages in rat vein graftsNicholas S Heaton, Randal A Wolff, Rita L Malinowski, et al.
Science (New York, N.Y.)|January 15, 2021
GPER1 is required to protect fetal health from maternal inflammationAlfred T Harding, Marisa A Goff, Heather M Froggatt, et al.
Journal of Vascular Surgery|May 9, 2006
Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmonRandal A Wolff, Rita L Malinowski, Nicholas S Heaton, et al.
The Journal of Experimental Medicine|August 20, 2014
Long-term survival of influenza virus infected club cells drives immunopathologyNicholas S Heaton, Ryan A Langlois, David Sachs, et al.
Plos Pathogens|January 22, 2025
Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategyXinyu Zhu, Zhaochen Luo, Rebecca A Leonard, et al.
Mbio|May 5, 2026
Constitutive interferon epsilon expression shapes antiviral epithelial states in the female reproductive tract and intestineRebecca L Casazza, Samantha Skavicus, David Hare, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Science Signaling|July 14, 2021
ETV7 limits antiviral gene expression and control of influenza virusesHeather M Froggatt, Alfred T Harding, Ryan R Chaparian, et al.
Mbio|June 8, 2017
Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in EggsAlfred T Harding, Brook E Heaton, Rebekah E Dumm, et al.
Plos Pathogens|November 16, 2019
Influenza viruses that require 10 genomic segments as antiviral therapeuticsAlfred T Harding, Griffin D Haas, Benjamin S Chambers, et al.
Mbio|January 2, 2025
Influenza B virus infection alters the regenerative potential of murine alveolar type 2 pneumocytesSatoko Nakano, Cait E Hamele, Aleksandra Tata, et al.
Journal of Vascular Research|March 21, 2008
Antisense to transforming growth factor-beta(1) facilitates the apoptosis of macrophages in rat vein graftsNicholas S Heaton, Randal A Wolff, Rita L Malinowski, et al.
Science (New York, N.Y.)|January 15, 2021
GPER1 is required to protect fetal health from maternal inflammationAlfred T Harding, Marisa A Goff, Heather M Froggatt, et al.
Journal of Vascular Surgery|May 9, 2006
Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmonRandal A Wolff, Rita L Malinowski, Nicholas S Heaton, et al.
The Journal of Experimental Medicine|August 20, 2014
Long-term survival of influenza virus infected club cells drives immunopathologyNicholas S Heaton, Ryan A Langlois, David Sachs, et al.
Plos Pathogens|January 22, 2025
Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategyXinyu Zhu, Zhaochen Luo, Rebecca A Leonard, et al.
Mbio|May 5, 2026
Constitutive interferon epsilon expression shapes antiviral epithelial states in the female reproductive tract and intestineRebecca L Casazza, Samantha Skavicus, David Hare, et al.
Pageof 9